Kalbe Farma Tbk PT
IDX:KLBF

Watchlist Manager
Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT
IDX:KLBF
Watchlist
Price: 1 485 IDR 1.37% Market Closed
Market Cap: 68.7T IDR
Have any thoughts about
Kalbe Farma Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one KLBF stock under the Base Case scenario is 1 432.27 IDR. Compared to the current market price of 1 485 IDR, Kalbe Farma Tbk PT is Overvalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KLBF Intrinsic Value
1 432.27 IDR
Overvaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Kalbe Farma Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KLBF cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KLBF?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Kalbe Farma Tbk PT

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Kalbe Farma Tbk PT

Provide an overview of the primary business activities
of Kalbe Farma Tbk PT.

What unique competitive advantages
does Kalbe Farma Tbk PT hold over its rivals?

What risks and challenges
does Kalbe Farma Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kalbe Farma Tbk PT.

Provide P/S
for Kalbe Farma Tbk PT.

Provide P/E
for Kalbe Farma Tbk PT.

Provide P/OCF
for Kalbe Farma Tbk PT.

Provide P/FCFE
for Kalbe Farma Tbk PT.

Provide P/B
for Kalbe Farma Tbk PT.

Provide EV/S
for Kalbe Farma Tbk PT.

Provide EV/GP
for Kalbe Farma Tbk PT.

Provide EV/EBITDA
for Kalbe Farma Tbk PT.

Provide EV/EBIT
for Kalbe Farma Tbk PT.

Provide EV/OCF
for Kalbe Farma Tbk PT.

Provide EV/FCFF
for Kalbe Farma Tbk PT.

Provide EV/IC
for Kalbe Farma Tbk PT.

Show me price targets
for Kalbe Farma Tbk PT made by professional analysts.

What are the Revenue projections
for Kalbe Farma Tbk PT?

How accurate were the past Revenue estimates
for Kalbe Farma Tbk PT?

What are the Net Income projections
for Kalbe Farma Tbk PT?

How accurate were the past Net Income estimates
for Kalbe Farma Tbk PT?

What are the EPS projections
for Kalbe Farma Tbk PT?

How accurate were the past EPS estimates
for Kalbe Farma Tbk PT?

What are the EBIT projections
for Kalbe Farma Tbk PT?

How accurate were the past EBIT estimates
for Kalbe Farma Tbk PT?

Compare the revenue forecasts
for Kalbe Farma Tbk PT with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kalbe Farma Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kalbe Farma Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kalbe Farma Tbk PT compared to its peers.

Compare the P/E ratios
of Kalbe Farma Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Kalbe Farma Tbk PT with its peers.

Analyze the financial leverage
of Kalbe Farma Tbk PT compared to its main competitors.

Show all profitability ratios
for Kalbe Farma Tbk PT.

Provide ROE
for Kalbe Farma Tbk PT.

Provide ROA
for Kalbe Farma Tbk PT.

Provide ROIC
for Kalbe Farma Tbk PT.

Provide ROCE
for Kalbe Farma Tbk PT.

Provide Gross Margin
for Kalbe Farma Tbk PT.

Provide Operating Margin
for Kalbe Farma Tbk PT.

Provide Net Margin
for Kalbe Farma Tbk PT.

Provide FCF Margin
for Kalbe Farma Tbk PT.

Show all solvency ratios
for Kalbe Farma Tbk PT.

Provide D/E Ratio
for Kalbe Farma Tbk PT.

Provide D/A Ratio
for Kalbe Farma Tbk PT.

Provide Interest Coverage Ratio
for Kalbe Farma Tbk PT.

Provide Altman Z-Score Ratio
for Kalbe Farma Tbk PT.

Provide Quick Ratio
for Kalbe Farma Tbk PT.

Provide Current Ratio
for Kalbe Farma Tbk PT.

Provide Cash Ratio
for Kalbe Farma Tbk PT.

What is the historical Revenue growth
over the last 5 years for Kalbe Farma Tbk PT?

What is the historical Net Income growth
over the last 5 years for Kalbe Farma Tbk PT?

What is the current Free Cash Flow
of Kalbe Farma Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kalbe Farma Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kalbe Farma Tbk PT

Current Assets 16.9T
Cash & Short-Term Investments 3.8T
Receivables 5.7T
Other Current Assets 7.3T
Non-Current Assets 11.7T
Long-Term Investments 454.8B
PP&E 8.6T
Intangibles 2.2T
Other Non-Current Assets 395.9B
Current Liabilities 4.3T
Accounts Payable 2T
Accrued Liabilities 630.5B
Short-Term Debt 560.2B
Other Current Liabilities 1T
Non-Current Liabilities 2.5T
Long-Term Debt 377.8B
Other Non-Current Liabilities 2.1T
Efficiency

Earnings Waterfall
Kalbe Farma Tbk PT

Revenue
31.6T IDR
Cost of Revenue
-19.8T IDR
Gross Profit
11.8T IDR
Operating Expenses
-7.8T IDR
Operating Income
3.9T IDR
Other Expenses
-902.6B IDR
Net Income
3T IDR

Free Cash Flow Analysis
Kalbe Farma Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KLBF Profitability Score
Profitability Due Diligence

Kalbe Farma Tbk PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Free Cash Flow
57/100
Profitability
Score

Kalbe Farma Tbk PT's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

KLBF Solvency Score
Solvency Due Diligence

Kalbe Farma Tbk PT's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
87/100
Solvency
Score

Kalbe Farma Tbk PT's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KLBF Price Targets Summary
Kalbe Farma Tbk PT

Wall Street analysts forecast KLBF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KLBF is 1 790.1 IDR with a low forecast of 1 565.5 IDR and a high forecast of 2 310 IDR.

Lowest
Price Target
1 565.5 IDR
5% Upside
Average
Price Target
1 790.1 IDR
21% Upside
Highest
Price Target
2 310 IDR
56% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KLBF?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for KLBF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Kalbe Farma Tbk PT Logo
Kalbe Farma Tbk PT

Country

Indonesia

Industry

Pharmaceuticals

Market Cap

68.7T IDR

Dividend Yield

2.09%

Description

PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 12,334 full-time employees. The firm provides healthcare solution through its four business divisions: the prescription pharmaceutical division, consumer health, nutritional, and distribution and logistics divisions. Its Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. Its Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.

Contact

DKI JAKARTA
Jakarta
Gedung KALBE Let.Jend Suprato Kav. 4
+6242873888.0
www.kalbe.co.id

IPO

1991-07-30

Employees

12 334

Officers

President Director
Mr. . Vidjongtius
Director of Human Resources, General Affairs & HSSE
Ms. Lanny Soputro
Director of Corporate Business Development, Management System & Regulatory Affairs and Director
Mr. Sie Djohan
Head of Internal Audit Unit
Mr. Rustam Tan
Corporate Secretary
Maria Teresa Fabiola

See Also

Discover More
What is the Intrinsic Value of one KLBF stock?

The intrinsic value of one KLBF stock under the Base Case scenario is 1 432.27 IDR.

Is KLBF stock undervalued or overvalued?

Compared to the current market price of 1 485 IDR, Kalbe Farma Tbk PT is Overvalued by 4%.

Back to Top